Bioactivity of Nisin-Loaded Pluronic Microspheres Challenged by Blood Proteins Julie Auxier Dr. Joseph McGuire - Bioengineering Oregon State University.

Slides:



Advertisements
Similar presentations
Coagulation Or Clotting of Blood
Advertisements

Haemostasis Prof. K. Sivapalan.
Hemostasis and Blood Coagulation Events in Hemostasis The term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis.
 More than 1.2 million people worldwide suffer from end-stage renal disease (ESRD) in their kidneys  Increasing at 6-7% annually  Require hemodialysis.
 In the United States over 300 million central venous catheters are used each year  200,000 users of these catheters are subject to life- threatening.
Haemostasis and NovoSeven®
Coagulation (the basics) and recombinant Factor VIIa Mechanism of Action Jerrold H. Levy, MD Emory University School of Medicine and Emory Healthcare Atlanta,
Basic Principles of Hemostasis
Hemostasis: Dr.Faten Hemostasis: Hemo/Stasis Hemo=BleedigStasis=Stop.
CHAPTER13 Biomaterials and Thrombosis 13-1 Introduction: Overview of Hemostasis Blood-Biomaterials Interaction via protein coats ---- blood coagulation.
HEMOSTASIS. Due to damaged blood vessels Events that stop bleeding.
Abstract This experiment was done to test the efficiency of transdermal patches in delivering lantibiotics through the surface of a membrane by diffusion.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Functionalization of Surfaces with Nisin in a Poly[ethylene oxide] brush layer Matt Ryder Dr. Joe McGuire – BioEngineering OSU HHMI Summer ‘07.
Blood Course By Dr. Khidir Abdel Galil.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Hemostasis and Blood Coagulation BS 4 th Semester Arsalan Yousuf.
Coagulation Cascade Ahmad Shihada Silmi Msc,FIBMS IUG Faculty of Science Medical Technology Dept.
Hemostasis and Blood Coagulation
Implant of a Medical Device and the Wound Healing Process.
Section 10: Nutrients and their functions Vitamin K and blood clot formation 01/27/06.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Provided by Central Web Services Implantable Medical Device Coatings for Prevention.
The effect of TCDD on cytokine production during the progression of insulitis in NOD mice Tuan Pham Dr. Nancy Kerkvliet Environmental and Molecular Toxicology.
Dr Mahvash Khan MBBS, MPhil. ◦ Occurs inside the blood vessels, it is also called fibrinolysis ◦ Occurs due to a substance known as plasmin (fibrinolysin)
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
WARFARIN AN OVERVIEW.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.
Protective functions of blood Hemostasis system
Hemostasis & blood coagulation Dr. Wasif Haq. Hemostasis Hemostasis: prevention of blood loss. Is hemostasis same as homeostasis?
Coagulation Mechanisms
Hemostasis and blood coagulation Lecture by Dr Sandeep :30-10:30 am.
Blood – Part 3. Hemostasis  Hemostasis – Stoppage of blood flow.  If a blood vessel wall breaks a series of reactions is set in motion.  This response.
Antimicrobial Coatings By Nikki Buck and David Brink-Roby Mentors: Danielle Leiske and Alia Mulder.
Clot Formation Review with Animations
Dr. S. Parthasarathy MD DA DNB PhD (physio) Mahatma Gandhi medical college and research institute, puducherry – India Prothrombin time.
The Clotting Cascade and DIC Karim Rafaat, MD. Coagulation Coagulation is a host defense system that maintains the integrity of the high pressure closed.
Blood Clotting Pathway. Prothrombin Thrombin Vitamin K Adds γCOO- to glutamate of prothrombin Also VII IX X Coumadin Inhibits vit K action.
Haemostasis Dr.Salah Elmalik Department of Physiology
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
Investigation of Haemostasis MS. c. program Lab-9.
ATH: A Novel Heparin-Based Anticoagulant
HAEMOSTASIS & FIBRINOLYSIS
Attachment of ADH Modified Heparin onto Silica Wafers By Amy Mayberry & Jonathan McGrath Mentors: Brianna Anderson-Gregg, Hyo Jin, and Omkar Oregon State.
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
Physiology of Blood. Platelets Small granulated non-nucleated bodies 2-4 micron in diameter Life span….. 8 days Count…300,000/mm 3.
Coagulation and fibrinolysis
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
Blood Plasma Plasma –Liquid part of blood –Clear, straw-colored fluid –90% water and 10% solutes –Solutes 6% to 8% of solutes are proteins –Albumins—helps.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
بسم الله الرحمن الرحيم.
REOLOGICAL PROPERTIES OF BLOOD. Reology Reology is the about the flowing of blood. Reology is a strong friction which arise in the case of fluids’ layers.
Blood Coagulation Dr Mahvash Khan MBBS, MPhil Hemostasis The third mechanism by which Hemostasis can be achieved is by formation of a blood clot.
Blood coagulation. Blood coagulation Blood coagulation Conversion of fluid state of blood into semisolid state by activation and interaction of pro-coagulants.
Platelets (Thrombocytes)
CHAPTER 17 BLOOD.
Secondary Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Coagulation Cascade of the Newborn
Anti-Coagulants Physical Process of Clotting
Implant of a Medical Device and the Wound Healing Process.
General Principles of Hemostasis Kristine Krafts, M.D.
Preventing Blood Loss a,b,c,d.
Hemostasis and blood coagulation Dr.sahar j kadhum
Coagulation.
Presentation transcript:

Bioactivity of Nisin-Loaded Pluronic Microspheres Challenged by Blood Proteins Julie Auxier Dr. Joseph McGuire - Bioengineering Oregon State University HHMI Summer 2008

Infected Hospitals Infections are the 4th largest killer in US In the US in 2005 there were: ▫94,360 invasive MRSA infections ▫18,650 associated deaths Costs millions annually Healthcare-Associated Community-Associated Source: ABCs Population-based surveillance System, Klevens et al. JAMA 2007 MRSA Infections in 2005

Infected Hospitals Problems from implanted devices: ▫Clotting ▫Bacterial adhesion ▫Proliferation Treat with heparin and other anticoagulants ▫Risk of platelet depletion, excessive bleeding

Blood Proteins Albumin, globulin, fibrinogen Fibrinogen key in coagulation Intrinsic Pathway Extrinsic Pathway Tissue Damage Tissue Factor III Factor VII Tissue Factor Complex Clotting Factor VII Activated Proenzymes, usually Factor XIII Platelet Factor PF-3 Clotting Factors VIII, IX Factor X Activator Complex Ca 2+ Fibrinogen Fibrin Prothrombin Thrombin Factor X Prothrombinase Common Pathway

Prevention with Pluronic ® F108 HYDROPHOBIC HYDROPHILIC HYDROPHOBIC SURFACE PEO PPO

Irradiating F108 Surfaces Hydrophobic association not permanent Irradiation creates a covalent bond between the F108 and the silanized silica Fluid flow will not wash away F108

HYDROPHOBIC BACTERIA PROTEIN How Brush Layer Functions

Nisin - Lantibiotic Bacteriocin: peptide produced by bacteria to inactivate other like bacteria Naturally made from bacteria Lactococcus lactis Used in food products: p reservative, making cheese

How Nisin Kills Bacteria

Purpose Challenge Nisin-loaded F108 silica microspheres with blood proteins to quantify protein adsorption to the brush layer.

Predictions Microspheres treated with irradiated F-108 will deflect protein adsorption throughout the entire trial; however, the efficacy of nisin treated samples will decline with time.

Efficacy Test: Silanize bare silica microspheres (~1μm in diameter) Covalently bond F108 by γ irradiation Plate samples with diluted Pediococcus pentosaceus Add nisin Challenge with blood proteins Quantify with colony counting

Silanized Silica Microspheres Horse PlasmaNisin γ F108 Nisin Horse Plasma No Nisin Horse Plasma M MNMFMFN MSMNS MFSMFNS

Effect of Nisin on Pediococcus PED MN MFN MFNS MNS

Results

Future Research Further work on behavior of protein adsorption Test platelet adhesion by challenging the same surfaces with platelet rich plasma Apply the coating to devices in vivo

Acknowledgements Dr. Joseph McGuire Matthew Ryder McGuire Lab Group Dr. Skip Rochefort Dr. Kevin Ahern Howard Hughes Medical Institute Johnson Internship Program